» Authors » A Herreros

A Herreros

Explore the profile of A Herreros including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 66
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Y, Gomez G, Ascaso C, Herreros A, Fornes B, Mases J, et al.
Clin Transl Oncol . 2021 Dec; 24(5):875-881. PMID: 34854030
Purpose: To evaluate the preliminary results of the use of 68 Gy EQD2 as a dose limit to the lowest dose in the most exposed 2 cm of the vagina...
2.
Oses G, Cases C, Valduvieco I, Farrus B, Alonso I, Caparros X, et al.
Clin Transl Oncol . 2021 Feb; 23(8):1593-1600. PMID: 33534078
Purpose: The administration of a dose boost to the tumor bed after breast-conserving surgery has proven to reduce local recurrence. Intra-operative electron radiotherapy (IOERT) offers an alternative method to deliver...
3.
Zhang Y, Ascaso C, Herreros A, Sanchez J, Del Pino M, Torne A, et al.
Clin Transl Oncol . 2019 Dec; 22(8):1295-1302. PMID: 31865604
Purpose: To determine whether brachytherapy with a single hypofractionated dose of 7 Gy provides the similar vaginal-cuff relapses and safety profile in terms of complications compared to schedules of 2...
4.
Rovirosa A, Cortes K, Ascaso C, Glickman A, Valdes S, Herreros A, et al.
Clin Transl Oncol . 2018 Apr; 20(11):1416-1421. PMID: 29651671
Objective: To analyze the impact of age on radiotherapy results based on cancer-specific survival (CSS), vaginal-cuff relapses (VCR) and complications analysis in 438 patients with endometrial carcinoma (EC) receiving postoperative...
5.
Rios I, Rovirosa A, Ascaso C, Valduvieco I, Herreros A, Castilla L, et al.
Clin Transl Oncol . 2015 Dec; 18(9):925-30. PMID: 26661111
Purpose: To analyze the vaginal-cuff local control (VCC) and toxicity in postoperative endometrial carcinoma patients (EC) underwent high-dose-rate brachytherapy (HDR-BT) administered daily. Materials And Methods: 154 consecutive patients received postoperative...
6.
Bueno C, Sardina J, Di Stefano B, Romero-Moya D, Munoz-Lopez A, Ariza L, et al.
Leukemia . 2015 Oct; 30(3):674-82. PMID: 26500142
B cells have been shown to be refractory to reprogramming and B-cell-derived induced pluripotent stem cells (iPSC) have only been generated from murine B cells engineered to carry doxycycline-inducible Oct4,...
7.
Rovirosa A, Anchuelo J, Crispin V, Gutierrez C, Herreros A, Herruzo I, et al.
Clin Transl Oncol . 2015 Apr; 17(8):581-9. PMID: 25893433
The endoesophageal brachytherapy technique provides good results in the treatment of oesophageal cancer, when indicated. In a consensus meeting, the Spanish Brachytherapy Group of SEOR and the Spanish Society of...
8.
Valduvieco I, Rovirosa A, Herreros A, Romera I, Rios I, Ascaso C, et al.
Clin Transl Oncol . 2012 Dec; 15(8):602-7. PMID: 23263910
Background: High-dose-rate brachytherapy (HDR-BT) is an accepted part of treatment for endometrial carcinoma and is usually performed in 1-2 fractions per week using different total doses and doses per fraction....
9.
Bover J, Lloret M, daSilva I, Furlano M, Diaz M, Herreros A, et al.
Contrib Nephrol . 2012 Jun; 178:124-142. PMID: 22652728
Chronic kidney disease (CKD), including patients on peritoneal dialysis (PD), is linked to an important increase in mortality risk. Within the new systemic term CKD-MBD, alterations in vitamin D metabolism...
10.
Martinez J, Martinez E, Herreros A
Nefrologia . 2005 Jul; 25 Suppl 2:3-9. PMID: 16050394
Acute renal failure (ARF) is an abrupt decline of renal function, and acute tubular necrosis (ATN) is its more frequent expression. Recent contributions in physiopathological knowledge, specially in post-ischemic ARF,...